• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.
Members

Institution

University of Alberta

City

Edmonton

Contact This Member

Stephane Bourque

Dr. Stephane Bourque is an Assistant Professor in the Departments of Anesthesiology & Pain Medicine, Pharmacology and Pediatrics at the University of Alberta

Dr. Stephane Bourque is an Assistant Professor in the Departments of Anesthesiology & Pain Medicine, Pharmacology and Pediatrics at the University of Alberta. He currently holds a Tier 2 Canada Research Chair in Developmental and Integrative Cardiovascular Pharmacology. He received his PhD from Queen’s University in 2009, and then pursued a postdoctoral fellowship at the University of Alberta before joining its faculty in 2014.

His research program encompasses two broad areas of cardiovascular pharmacology. The first focuses on understanding how iron deficiency in pregnancy affects growth and development of the fetus, and in turn predisposes the offspring to cardiovascular disease in later life. Iron deficiency Is the most common nutritional deficiency worldwide, and pregnant women are among the most susceptible. Diagnosis and treatment for iron deficiency in pregnancy is deceptively complex, which underscores the high prevalence despite widespread supplementation and food-fortification efforts. The goal of his work is to develop tools to diagnose iron deficiency and anemia earlier in pregnancy, and novel therapeutics to improve outcomes in these complicated pregnancies. The second focuses on understanding the mechanisms underlying the development of vasoplegia and cardiovascular collapse in the progression from sepsis to septic shock.  More recently, his team has also begun studying the implications of neonatal sepsis and recovery on subsequent cardiovascular development and function in adulthood.

His research program is currently funded by the Canadian Institutes of Health Research, the Women and Children’s Health Research Institute at the University of Alberta, the Canadian Foundation for Innovation, and the Royal Alexandra Hospital Foundation.